Biological changes in C57BL/6 mice following 3 weeks of inhalation exposure to cigarette smoke or e-vapor aerosols

Inhalation Toxicology

Volumn 30, Issue 13-14, 2018, Pages 553-567

  Lee, K Monica ^a   Hoeng, Julia ^b   Harbo, Sam ^c   Kogel, Ulrike ^b   Gardner, William ^a   Oldham, Michael ^a   Benson, Eric ^c   Talikka, Marja ^b   Kondylis, Athanasios ^b   Martin, Florian ^b   Titz, Bjoern ^b   Ansari, Sam ^b   Trivedi, Keyur ^b   Guedj, Emmanuel ^b   Elamin, Ashraf ^b   Ivanov, Nikolai V ^b   Vanscheeuwijck, Patrick ^b   Peitsch, Manuel C ^b   McKinney, Willie J ^a  

^a Altria Client Services   (United States)

^b PMI R D   (Switzerland)

^c BATTELLE MEMORIAL INSTITUTE   (United States)

Author keywords

3R4F; aerosols; e cigarette; e vapor; inhalation; MarkTen ; mice; proteomics; transcriptomics

Indexed keywords

ACETALDEHYDE; ACROLEIN; BIOLOGICAL MARKER; CARBOXYHEMOGLOBIN; CATHEPSIN S; CIGARETTE SMOKE; COTININE; CROTONALDEHYDE; FORMALDEHYDE; GELATINASE B; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6; INTERLEUKIN 7; MACROPHAGE ELASTASE; NICOTINE; PROPIONALDEHYDE; PROTEOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT GAIN; C57BL 6 MOUSE; CD3+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; EPIGLOTTIS; EXPOSURE; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HISTIOCYTE; HISTOPATHOLOGY; HUMIDITY; IMMUNOPHENOTYPING; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; LUNG ALVEOLUS MACROPHAGE; LUNG INFILTRATE; LUNG LAVAGE; LUNG WEIGHT; MOUSE; NONHUMAN; OSMOTIC STRESS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEOMICS; SQUAMOUS CELL METAPLASIA; TRANSCRIPTOMICS; UPREGULATION; VAPING; AEROSOL; ANIMAL; BRONCHOALVEOLAR LAVAGE FLUID; C57BL MOUSE; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; ELECTRONIC CIGARETTE; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION TEST; METABOLISM; PATHOLOGY; RESPIRATORY FUNCTION; RESPIRATORY SYSTEM; SMOKE; TOBACCO;

ADMINISTRATION, INHALATION; AEROSOLS; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CARBOXYHEMOGLOBIN; ELECTRONIC NICOTINE DELIVERY SYSTEMS; FEMALE; GENE EXPRESSION PROFILING; MICE, INBRED C57BL; RESPIRATORY FUNCTION TESTS; RESPIRATORY PHYSIOLOGICAL PHENOMENA; RESPIRATORY SYSTEM; SMOKE; TOBACCO PRODUCTS;

EID: 85062791846     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.1080/08958378.2019.1576807     Document Type: Article

References (47)

1. Ackermann M, Strimmer K. (2009). A general modular framework for gene set enrichment analysis. BMC Bioinformatics 10:47.
2. Benjamini Y, Hochberg Y. (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 57:289–300.
3. Bradford MM. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–54.
4. Cervellati F, Muresan XM, Sticozzi C, et al. (2014). Comparative effects between electronic and cigarette smoke in human keratinocytes and epithelial lung cells. Toxicol in Vitro 28:999–1005.
5. Cheng T. (2014). Chemical evaluation of electronic cigarettes. Tob Control 23 Suppl 2:ii11–7.
6. [CORESTA] Cooperation Centre for Scientific Research Relative to Tobacco. (2015). CORESTA recommended method N° 81, routine analytical machine for e-cigarette aerosol generation and collection–definitions and standard conditions; [accessed 2018 July 4]. Available from: https://www.coresta.org/sites/default/files/technical_documents/main/CRM_81.pdf.
7. Crotty Alexander LE, Drummond CA, Hepokoski M, et al. (2018). Chronic inhalation of e-cigarette vapor containing nicotine disrupts airway barrier function and induces systemic inflammation and multiorgan fibrosis in mice. Am J Physiol Integr Comp Physiol 314:R834–47.
8. [FDA] Food and Drug Administration. (2016). Draft guidance for industry: premarket tobacco product applications for electronic nicotine delivery systems; [accessed 2018 July 4]. Available from: https://www.fda.gov/downloads/tobaccoproducts/labeling/rulesregulationsguidance/ucm499352.pdf.
9. Flora JW, Wilkinson CT, Wilkinson JW, et al. (2017). Method for the determination of carbonyl compounds in e-cigarette aerosols. J Chromatogr Sci 55:142–8.
10. Fujimoto H, Tsuji H, Okubo C, et al. (2015). Biological responses in rats exposed to mainstream smoke from a heated cigarette compared to a conventional reference cigarette. Inhal Toxicol 27:224–36.
11. Gautier L, Cope L, Bolstad BM, et al. (2004). affy--analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20:307–315. Available from: https://www.ncbi.nlm.nih.gov/pubmed/14960456
12. Glynos C, Bibli SI, Katsaounou P, et al. (2018). Comparison of the effects of e-cigarette vapor with cigarette smoke on lung function and inflammation in mice. Am J Physiol Lung Cell Mol Physiol 315:L662–72.
13. Goniewicz ML, Knysak J, Gawron M, et al. (2014). Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control 23:133–9.
14. Haussmann HJ, Fariss MW. (2016). Comprehensive review of epidemiological and animal studies on the potential carcinogenic effects of nicotine per se. Crit Rev Toxicol 46:701–34.
15. Herbrich SM, Cole RN, West KP, Jr, et al. (2013). Statistical inference from multiple iTRAQ experiments without using common reference standards. J Proteome Res 12:594–604.
16. Hoeng J, Talikka M, Martin F, et al. (2014). Case study: the role of mechanistic network models in systems toxicology. Drug Discov Today 19:183–92.
17. Huber W, Von Heydebreck A, Sültmann H, et al. (2002). Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18:S96–S104.
18. Hultin-Rosenberg L, Forshed J, Branca RM, et al. (2013). Defining, comparing, and improving iTRAQ quantification in mass spectrometry proteomics data. Mol Cell Proteomics 12:2021–31.
19. Kanehisa M, Furumichi M, Tanabe M, et al. (2017). KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res 45:D353–61.
20. Martin F, Sewer A, Talikka M, et al. (2014). Quantification of biological network perturbations for mechanistic insight and diagnostics using two-layer causal models. BMC Bioinformatics 15:238.
21. McCall MN, Bolstad BM, Irizarry RA. (2010). Frozen robust multiarray analysis (fRMA). Biostatistics 11:242–53.
22. McRobbie H, Phillips A, Goniewicz ML, et al. (2015). Effects of switching to electronic cigarettes with and without concurrent smoking on exposure to nicotine, carbon monoxide, and acrolein. Cancer Prev Res (Phila) 8:873–8.
23. Ménache MG, Miller FJ, Raabe OB. (1995). Particle inhalability curves for humans and small laboratory animals. Ann Occup Hyg 39:317–28.
24. Misra M, Leverette RD, Cooper BT, et al. (2014). Comparative in vitro toxicity profile of electronic and tobacco cigarettes, smokeless tobacco and nicotine replacement therapy products: e-liquids, extracts and collected aerosols. Int J Environ Res Public Health 11:11325–47.
25. [NAS] National Academies of Sciences, Engineering, and Medicine. (2018). Committee on the review of the health effects of electronic nicotine delivery systems. Public health consequences of e-cigarettes. Washington (DC): The National Academies Press.
26. [NRC] National Research Council. (2011). Guide for the care and use of laboratory animals. 8th ed. Washington, DC: The National Academies Press.
27. Nutt DJ, Phillips LD, Balfour D, et al. (2014). Estimating the harms of nicotine-containing products using the MCDA approach. Eur Addict Res 20:218–25.
28. Obot CJ, Lee K, Fuciarelli AF, et al. (2004). Characterization of mainstream cigarette smoke (MS)-induced biomarker responses in ICR and C57Bl/6 mice. Inhal Toxicol 16:701–19.
29. Ogunwale MA, Li M, Ramakrishnam Raju MV, et al. (2017). Aldehyde detection in electronic cigarette aerosols. ACS Omega 2:1207–14.
30. [OECD] Organisation for economic co-operation and development. (2009). Guidance document on acute inhalation toxicity testing, No. 39; [accessed 2018 Sept 16]. Available from: https://ntp.niehs.nih.gov/iccvam/suppdocs/feddocs/oecd/oecd-gd39.pdf.
31. Phillips B, Titz B, Kogel U, et al. (2017). Toxicity of the main electronic cigarette components, propylene glycol, glycerin, and nicotine, in Sprague-Dawley rats in a 90-day OECD inhalation study complemented by molecular endpoints. Food Chem Toxicol 109:315–32.
32. Phillips B, Veljkovic E, Boué S, et al. (2016). An 8-month systems toxicology inhalation/cessation study in Apoe-/- mice to investigate cardiovascular and respiatory exposure effects of a candidate modified risk tobacco product, THS 2.2, compared with conventional cigarettes. Toxicol Sci 149:411–32.
33. Phillips B, Veljkovic E, Peck MJ, et al. (2015). A 7-month cigarette smoke inhalation study in C57BL/6 mice demonstrates reduced lung inflammation and emphysema following smoking cessation or aerosol exposure from a prototypic modified risk tobacco product. Food Chem Toxicol 80:328–45.
34. Raabe OG, Al-Bayati MA, Teague SV, Rasolt A. (1988). Regional deposition of inhaled monodisperse coarse and fine aerosol particles in small laboratory animals. Ann Occup Hyg 31:53–63.
35. [RCP UK] Royal College of Physicians. (2016). Nicotine without smoke: tobacco harm reduction; [accessed 2018 July 4]. Available from: https://www.rcplondon.ac.uk/projects/outputs/nicotine-without-smoke-tobacco-harm-reduction-0.
36. Smyth GK. (2004). Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3:Article3.
37. St Helen G, Havel C, Dempsey DA, et al. (2016). Nicotine delivery, retention and pharmacokinetics from various electronic cigarettes. Addiction 111:535–44.
38. Talikka M, Boue S, Schlage WK. (2015). Causal biological network database: a comprehensive platform of causal biological network models focused on the pulmonary and vascular systems. In: Hoeng J, Peitsch MC, editors. Computational systems toxicology. New York, NY: Humana Press. p. 65–93.
39. Taylor M, Carr T, Oke O, et al. (2016). E-cigarette aerosols induce lower oxidative stress in vitro when compared to tobacco smoke. Toxicol Mech Methods 26:465–76.
40. Thomson TM, Sewer A, Martin F, et al. (2013). Quantitative assessment of biological impact using transcriptomic data and mechanistic network models. Toxicol Appl Pharmacol 272:863–78.
41. Tsuji H, Fujimoto H, Lee KM, et al. (2015). Characterization of biochemical, functional and structural changes in mice respiratory organs chronically exposed to cigarette smoke. Inhal Toxicol 27:342–53.
42. Tsuji H, Fujimoto H, Matsuura D, et al. (2011). Comparison of mouse strains and exposure conditions in acute cigarette smoke inhalation studies. Inhal Toxicol 23:602–15.
43. U.S. Department of Health and Human Services (US DHHS) (2014). The Health Consequences of Smoking—50 Years of Progress. A Report of the Surgeon General. Available from https://www.surgeongeneral.gov/library/reports/50-years-of-progress/exec-summary.pdf.
44. Vansickel AR, Edmiston JS, Liang Q, et al. (2018). Characterization of puff topography of a prototype electronic cigarette in adult exclusive cigarette smokers and adult exclusive electronic cigarette users. Regul Toxicol Pharmacol 98:250–6.
45. Wagner KA, Flora JW, Melvin MS, et al. (2018). An evaluation of electronic cigarette formulations and aerosols for harmful and potentially harmful constituents (HPHCs) typically derived from combustion. Regul Toxicol Pharmacol 95:153–60.
46. Werley MS, Kirkpatrick DJ, Oldham MJ, et al. (2016). Toxicological assessment of a prototype e-cigaret cartridge and three flavor formulations: a 90-day inhalation study in rats. Inhal Toxicol 28:22–38.
47. Werley MS, McDonald P, Lilly P, et al. (2011). Non-clinical safety and pharmacokinetic evaluations of propylene glycol aerosol in Sprague-Dawley rats and Beagle dogs. Toxicology 287:76–90.